Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET

Rhea-AI Summary

Cassava Sciences (Nasdaq: SAVA), a clinical-stage biotechnology company focusing on Alzheimer's disease, has announced a conference call scheduled for Thursday, August 8th, 2024, at 8:30 a.m. Eastern Time. The call aims to discuss recent developments and provide a company update.

Interested parties can access the audio webcast through the company's website or via a direct link. A replay of the webcast will be available for 90 days following the event on Cassava Sciences' Company Presentations page.

This announcement suggests that Cassava Sciences may have significant updates to share regarding their Alzheimer's research or company progress, potentially impacting their stock performance.

AUSTIN, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it will hold a conference call on Thursday, August 8^th at 8:30 a.m. Eastern Time.

Event details follow:
Date:	Thursday, August 8th
Time:	8:30 a.m. Eastern Time
Audio Webcast:	https://www.CassavaSciences.com/company-presentations
Or
Audio Webcast:	https://edge.media-server.com/mmc/p/zjvmjjcr

A replay of the audio webcast will also be available on the Company Presentations page of the Cassava Sciences’ website for 90 days following the webcast.

About Cassava Sciences, Inc.
Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Our novel science is based on stabilizing—but not removing—a critical protein in the brain.

For more information, please visit: https://www.CassavaSciences.com

For More Information Contact:
Eric Schoen, Chief Financial Officer
(512) 501-2450 or ESchoen@CassavaSciences.com

FAQ

When is Cassava Sciences (SAVA) holding its conference call to discuss recent developments?

Cassava Sciences (SAVA) is holding its conference call on Thursday, August 8th, 2024, at 8:30 a.m. Eastern Time.

How can investors access Cassava Sciences' (SAVA) upcoming conference call?

Investors can access Cassava Sciences' (SAVA) conference call via an audio webcast on the company's website or through a direct link provided in the press release.

What is the main focus of Cassava Sciences' (SAVA) research?

Cassava Sciences (SAVA) is a clinical-stage biotechnology company primarily focused on Alzheimer's disease research.

How long will the replay of Cassava Sciences' (SAVA) August 8th, 2024 conference call be available?

The replay of Cassava Sciences' (SAVA) conference call will be available for 90 days following the webcast on the Company Presentations page of their website.